Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network.

Autor: Abusrewil S; Medical school Tripoli university, Tripoli, Libya., Algeer A; Medical services directorate of the armed forces/Ministry of defense, Riyadh, Saudi Arabia., Aljifri A; Ministry of Health, Riyadh, Saudi Arabia., Al Slail F; Ministry of Health, Riyadh, Saudi Arabia., Andrew MK; Dalhousie University and Canadian Centre for Vaccinology, Halifax, Canada., Awad Tag Eldin M; Ministry of Health, Cairo, Egypt., Al Awaidy S; Ministry of Health, Mascate, Oman., Ben Alaya N; Ministry of Health, Tunis, Tunisia., Ben Khelil J; Hopital Abderrahmene Mami, Tunis, Tunisia., Dbaibo G; American University of Beirut, Beirut, Lebanon., Derrar F; Institut Pasteur d'Algerie, Algiers, Algeria., Elahmer O; National Centre for Disease Control, Tripoli, Libya., Ghosn N; Ministry of Public Health, Beirut, Lebanon., Gabriel G; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany., Grasso C; Fondation Mérieux, Lyon, France., Hassan M; Ministry of Health and Prevention, Abou Dabi, United Arab Emirates., Hirve S; World Health Organisation, Geneva, Switzerland., Mirza YK; Agha khan university, Karachi, Pakistan., Rateb YM; Ministry of Health, Amman, Jordan., Nourlil J; Institut Pasteur du Maroc, Casablanca, Morocco., Nunes MC; Faculty of Health Science, Department of Science/National Research Foundation: Vaccine Preventable Diseases Unit, Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Omaima I; Faculty of Medicine, Cairo University, Cairo, Egypt., Malande OO; Egerton University, Nakuru, Kenya & East Africa Centre for Vaccines and Immunization (ECAVI), Egerton, Kenya., Saadatian-Elahi M; Edouard Herriot Hospital, Lyon, France., Sanchez-Picot V; Fondation Mérieux, Lyon, France., Sk Mamunur Rahman M; World Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt., Tarraf H; Faculty of Medicine, Cairo University, Cairo, Egypt., Walaza S; National Institute of Communicable Disease (NICD), Johannesburg, South Africa.
Jazyk: angličtina
Zdroj: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2019 May; Vol. 13 (3), pp. 298-304. Date of Electronic Publication: 2019 Feb 22.
DOI: 10.1111/irv.12628
Abstrakt: The Middle-East and Africa Influenza Surveillance Network (MENA-ISN), established in 2014, includes 15 countries at present. Country representatives presented their influenza surveillance programmes, vaccine coverage and influenza control actions achieved, and provided a list of country surveillance/control objectives for the upcoming 3 years. This report details the current situation of influenza surveillance and action plans to move forward in MENA-ISN countries. Data were presented at the 8th MENA-ISN meeting, organized by the Mérieux Foundation that was held on 10-11 April 2018 in Cairo, Egypt. The meeting included MENA-ISN representatives from 12 countries (Algeria, Egypt, Jordan, Kenya, Lebanon, Libya, Morocco, Pakistan, Saudi Arabia, South Africa, Tunisia and United Arab Emirates) and experts from the Canadian Centre for Vaccinology, and the World Health Organization. Meeting participants concluded that influenza remains a significant threat especially in high-risk groups (children under-5, elderly, pregnant women and immunosuppressed individuals) in the MENA-ISN region. Additional funding and planning are required by member countries to contain this threat. Future meetings will need to focus on creative and innovative ways to inform policy and initiatives for vaccination, surveillance and management of influenza-related morbidity and mortality especially among the most vulnerable groups of the population.
(© 2018 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje